Underground Team's Ransomware Attack on Ethypharm
Analysis of the Ransomware Attack on Ethypharm by the Underground Team
Company Profile: Ethypharm
Ethypharm is a specialty pharmaceutical company that stands out in the healthcare sector due to its focus on the central nervous system (CNS) diseases, particularly targeting severe pain and opioid dependency. With a revenue of €334 million, Ethypharm plays a crucial role in developing and manufacturing innovative drug delivery solutions aimed at improving patient outcomes. Their products are essential in pain management, addiction treatment, and critical care, making them a key partner of the National Health Service (NHS) in the UK. The company's operations are primarily based in Romford, Greater London, where they maintain high standards in the manufacturing and distribution of pharmaceutical products.
Details of the Ransomware Attack
The ransomware group known as the Underground Team has recently targeted Ethypharm, claiming responsibility via their dark web leak site. This attack is significant as it involves the exfiltration of sensitive data, with threats to leak it unless a ransom is paid. The group's approach includes sophisticated tactics such as stopping target services, deleting Volume Shadow Copies, and clearing Windows event logs. They employ the 3DES algorithm with RSA encryption to lock the files, which complicates the decryption process without their cooperation.
Profile of the Underground Team Ransomware Group
The Underground Team is a financially motivated ransomware group that emerged in 2023. They are known for their novel encryption methods and have previously demanded ransoms as high as nearly $3 million. The group targets companies rather than individual users, focusing on extracting large ransom payments. Their operational tactics include advanced encryption techniques and a strategic choice of targets that are likely to yield high financial returns.
Potential Vulnerabilities and Entry Points
Ethypharm's significant reliance on digital technology for drug formulation and distribution might have exposed them to cyber threats. The sophistication of the Underground Team suggests that they could have exploited vulnerabilities in Ethypharm’s network, possibly through phishing attacks or unpatched software. The high value and sensitivity of the data handled by Ethypharm make it a lucrative target for ransomware attacks, emphasizing the need for robust cybersecurity measures in the pharmaceutical industry.
Sources
See Halcyon in action
Interested in getting a demo?
Fill out the form to meet with a Halcyon Anti-Ransomware Expert!